Final07A_testandkey - PABIO 201 FINAL EXAM FALL 2007...

Info iconThis preview shows pages 1–4. Sign up to view the full content.

View Full Document Right Arrow Icon
PABIO 201 F INAL E XAM F ALL 2007 M ONDAY , D ECEMBER 10 TH , 2007 Put name on BOTH the question and answer sheet. Write name at top of EACH page of question sheet. Use Scorepak PURPLE answer sheet, Use a #2 pencil Mark only one circle per question completely and neatly. Write the TEST VERSION on the Purple answer sheet. You are RESPONSIBLE for transferring correct answers to the computer sheet. Only answers on the computer sheet will be accepted. Answer ALL questions, including bonus questions, on purple sheet. Grade for final and course will be written on question sheet. Question sheets will be returned in a box in front of Dr. Kenny’s office at F161. If you wish to have your examination returned privately, give TA a note. No answers are intentionally MISSPELLED . We are not testing for spelling. Test Version: A Student Name: ______________________________________ Student Identification #: _____________________________
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
2 PABIO 201- Fall 2007 Final Exam Version A Monday, December 10, 2007 NAME: _______________________ 1. The “cardinal” signs of inflammation include all the following EXCEPT: A. Redness B. Numbness C. Swelling D. Warmth E. Pain 2. The global eradication of smallpox was possible for all of the following reasons EXCEPT: A. Viral transmission to an animal reservoir B. Viral transmission occurs only when illness is apparent C. Immunity develops after recovery from initial infection D. Vaccination provides long-lasting protection E. Concerted worldwide effort 3. The Select Agent List, Category A includes the most worrisome agents in bioterrorism. The list includes the following EXCEPT: A. Anthrax B. Plague C. MRSA D. Botulism E. Smallpox 4. Effective vaccines exist for all the following EXCEPT: A. Measles B. Tetanus C. Polio D. Malaria E. Diphtheria 5. Drug design includes consideration of the following characteristics EXCEPT: A. Static versus cidal activity B. Stability in blood versus stability in culture C. Bioavailability (oral versus IV) D. Activity against a pathogen versus toxicity against human cells E. In vitro versus in vivo activities 6. All of the following are true for adaptive immunity EXCEPT: A. Acquired after initial exposure to a pathogen B. Induced within one day of initial infection
Background image of page 2
3 PABIO 201- Fall 2007 Final Exam Version A Monday, December 10, 2007 NAME: _______________________ C. Primes the immune system for rapid response upon subsequent exposure to the same pathogen D. Involves interactions between T-cells and B-cells E. A goal for many vaccine development efforts 7. All of the following are financial considerations for a company in developing a drug against an emerging infection EXCEPT: A. The drug must make at least $500,000,000 to recover research and development costs. B.
Background image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 4
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 10/05/2009 for the course G H 201 taught by Professor White during the Fall '09 term at University of Washington.

Page1 / 16

Final07A_testandkey - PABIO 201 FINAL EXAM FALL 2007...

This preview shows document pages 1 - 4. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online